薄膜
发表于 2025-3-25 04:54:42
DNA Flow Cytometry Application to Clinical Trials in Breast Cancer, one of the best opportunities to assess new treatment strategies as well as evaluate new prognostic markers. Several prognostic factors are currently being evaluated in a number of clinical trials throughout the United States, the most well established of these markers is DNA flow cytometry.
Boycott
发表于 2025-3-25 08:59:52
http://reply.papertrans.cn/19/1813/181205/181205_22.png
commonsense
发表于 2025-3-25 11:54:01
The Clinical Potential of DNA Content Parameters in Human Pediatric and Adult Solid Tumors, technologies have evolved which have allowed the careful correlation of pathological features of tumors and the clinical outcome of the patients that harbor them. Until very recently, individual patient treatment decisions and the design of clinical trials were based primarily on these two types of parameters; clinical stage and histopathology.
漂浮
发表于 2025-3-25 16:08:37
The Molecular Basis for the Control of Mammalian Cell Growth, have been many spectacular advances in our understanding of the molecular processes that regulate cell proliferation. This review will outline our current understanding of the major features of cell growth regulation in mammalian cells.
大约冬季
发表于 2025-3-25 22:06:33
http://reply.papertrans.cn/19/1813/181205/181205_25.png
leniency
发表于 2025-3-26 01:44:12
EPR Investigation of Hydrogenases have been many spectacular advances in our understanding of the molecular processes that regulate cell proliferation. This review will outline our current understanding of the major features of cell growth regulation in mammalian cells.
Dna262
发表于 2025-3-26 07:04:28
http://reply.papertrans.cn/19/1813/181205/181205_27.png
抛射物
发表于 2025-3-26 09:52:54
http://reply.papertrans.cn/19/1813/181205/181205_28.png
伸展
发表于 2025-3-26 14:05:03
http://reply.papertrans.cn/19/1813/181205/181205_29.png
Certainty
发表于 2025-3-26 20:31:42
Maurice van Gastel,Wolfgang Lubitz functions and operates by forming temporary gates in double stranded DNA (Fig. 1) through which an intact helix can pass. Several classes of antitumor drugs are now recognized as topoisomerase poisons because of their ability to trap the enzyme gates on DNA in the form of stabilized cleavable complexes (Fig. 1).